A BIOMARKER OF BREAST CANCER
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jul 7, 2016
app pub date -
May 27, 2014
filing date -
May 27, 2013
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
The invention provides methods of and diagnostic kits for the detection of breast cancer or to assist in assessing the prognosis, cancer comprising a reagent capable of identifying a circulating miRNA, the miRNA being the miR-138 biomarker. The invention also provides methods of identifying a therapeutic agent capable of preventing or treating cancers, including breast cancer, comprising testing the ability of the potential therapeutic agent to reduce the expression of miR-138.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully